← Leaderboards
Mei-Chuan Ko
Wake Forest University Health Sciences
$10,197,993
Attributed
$10,197,993
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2008–24$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,197,993 · 14
By mechanism
R01$7,081,021 · 5
R21$3,116,972 · 8
P50$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Colleen A Hanlon$10,433,085
- Gil Yosipovitch$1,294,475
- Dean G Assimos$4,435,846
- Jospeh L Jorizzo$144,000
Others in their field
Top investigators on “Primates”
- Dennis R. Burton · Scripps Research Institute$282,976,433
- David Heimbrook · Leidos Biomedical Research, Inc.$244,980,072
- Richard A Gibbs · Baylor College Of Medicine$234,617,125
- Lawrence Corey · Fred Hutchinson Cancer Center$225,398,394
- Mark S Klempner · Tufts Medical Center$128,021,180
- Dan H. Barouch · Fred Hutchinson Cancer Center$119,529,020
Research focus
PrimatesBehavioralPharmaceutical PreparationsDoseNonhuman PrimateOpioid ReceptorMonkeysCommunitiesRodentEvaluationAdverse EffectsMacaca MulattaMedicalAgonistEffectivenessPhysiologicalAnalgesicsPruritusLigandsVentilatory DepressionPainAnimalsAbsence Of Pain SensationMorphine
Grant awards (35)
Functional efficacy of cannabidiol in modulating the adverse effects of heroin in primates.$232,500
R21 · FY2024 · DA · contact PI
Buprenorphine analogs for the treatment of opioid abuse$486,210
R01 · FY2023 · DA · contact PI
Buprenorphine analogs for the treatment of opioid abuse$697,628
R01 · FY2022 · DA · contact PI
Buprenorphine analogs for the treatment of opioid abuse$547,323
R01 · FY2021 · DA · contact PI
Effects of a G protein signaling-biased mu opioid receptor agonist SR-17018 in primates$205,966
R21 · FY2021 · DA · contact PI
Effects of a G protein signaling-biased mu opioid receptor agonist SR-17018 in primates$258,065
R21 · FY2020 · DA · contact PI
Diverse Effects of a Stress-Related Ligand, Corticotropin-Releasing Factor, in Non-Human Primates$193,750
R21 · FY2019 · DA · contact PI
Spinal BNP-NPRA Signaling in Regulating Itch and Pain in Primates$170,500
R21 · FY2019 · AR · contact PI
Diverse Effects of a Stress-Related Ligand, Corticotropin-Releasing Factor, in Non-Human Primates$232,500
R21 · FY2018 · DA · contact PI
Effects of a G protein-biased mu opioid receptor agonist PZM21 in primates$205,686
R21 · FY2018 · DA · contact PI
Spinal BNP-NPRA Signaling in Regulating Itch and Pain in Primates$204,600
R21 · FY2018 · AR · contact PI
Effects of a G protein-biased mu opioid receptor agonist PZM21 in primates$219,436
R21 · FY2017 · DA · contact PI
Pharmacological Studies of NOP Receptors$353,095
R01 · FY2016 · DA · contact PI
A novel spinal analgesic with mixed MOP/NOP actions in primates$154,289
R21 · FY2016 · DA · contact PI
Pharmacological Studies of NOP Receptors$351,051
R01 · FY2015 · DA · contact PI
A novel spinal analgesic with mixed MOP/NOP actions in primates$272,099
R21 · FY2015 · DA · contact PI
Pharmacological Studies of NOP Receptors$354,312
R01 · FY2014 · DA · contact PI
Effects of a Buprenorphine Analog with Mixed MOP/NOP Actions in Primates$185,000
R21 · FY2014 · DA · contact PI
Regulation of Itch Scratching by Spinal GRP Receptors in Primates$163,625
R21 · FY2014 · AR · contact PI
Pharmacological Studies of NOP Receptors$337,725
R01 · FY2013 · DA · contact PI
Behavioral Pharmacology of Itch$314,469
R01 · FY2013 · AR · contact PI
Effects of a Buprenorphine Analog with Mixed MOP/NOP Actions in Primates$223,881
R21 · FY2013 · DA · contact PI
Regulation of Itch Scratching by Spinal GRP Receptors in Primates$195,075
R21 · FY2013 · AR · contact PI
Pharmacological Studies of NOP Receptors$356,997
R01 · FY2012 · DA · contact PI
Behavioral Pharmacology of Itch$335,880
R01 · FY2012 · AR · contact PI
Behavioral Pharmacology of Itch$335,880
R01 · FY2011 · AR · contact PI
Evaluation in Primates of Cocaine Esterase for the Treatment of Cocaine Toxicity$509,123
R01 · FY2010 · DA · contact PI
Behavioral Pharmacology of Itch$348,001
R01 · FY2010 · AR · contact PI
Evaluation in Primates of Cocaine Esterase for the Treatment of Cocaine Toxicity$499,287
R01 · FY2009 · DA · contact PI
Evaluation in Primates of Cocaine Esterase for the Treatment of Cocaine Toxicity$519,373
R01 · FY2008 · DA · contact PI
Intrathecal Opioid-Induced Pruritus$244,889
R01 · FY2003 · DA
Intrathecal Opioid-Induced Pruritus$244,889
R01 · FY2002 · DA
ANALGESIA &RESPIRATION IN MONKEYS$0
P50 · FY2002 · DA
Intrathecal Opioid-Induced Pruritus$244,889
R01 · FY2001 · DA
ANALGESIA &RESPIRATION IN MONKEYS$0
P50 · FY2001 · DA